Cargando…
Therapeutic Delivery Methods.
This book provides a concise overview of emerging areas of therapeutic delivery methodology for readers who have preliminary backgrounds in pharmaceutical sciences, drug delivery or formulation.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Future Science Group,
2013.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Therapeutic delivery methods: concise overview of emerging areas
- Mechanism of gastrointestinal drug absorption and application in therapeutic drug delivery
- Pharmacokinetic and pharmacodynamic modeling of drug absorption and delivery
- Emerging oral controlled-release technology for optimal therapy
- Controlled delivery of macromolecules and peptides
- Responsive polymers for drug delivery
- Formulation and evaluation of nanopharmaceuticals in drug delivery
- Targeted drug delivery across biological barriers using polymer nanoparticles
- Solid lipid nanoparticles: a current approach to new drug-delivery systems in nanotechnologyCutting-edge techniques for molecular imaging with relevance to therapeutic delivery methods
- Administration routes for the delivery of vaccines and immunotherapeutics
- _GoBack
- _GoBack
- _ENREF_1
- OLE_LINK1
- OLE_LINK2
- _ENREF_2
- _ENREF_3
- _ENREF_4
- _ENREF_5
- _ENREF_6
- _ENREF_7
- _ENREF_8
- _ENREF_9
- _ENREF_14
- _ENREF_15
- _ENREF_16
- _ENREF_17
- _ENREF_18
- _ENREF_19
- _ENREF_10
- _ENREF_11
- _ENREF_12
- _ENREF_13Membrane permeation
- In vitro & in vivo methods to determine the effective permeability
- Gastric emptying & intestinal transit time
- GI absorption of nanocrystals
- _ENREF_1
- OLE_LINK3
- OLE_LINK4
- _ENREF_2
- _ENREF_3
- _ENREF_4
- _ENREF_5
- _ENREF_6
- _ENREF_7
- _ENREF_8
- _ENREF_10
- _ENREF_11
- _ENREF_12
- _ENREF_13
- _ENREF_14
- _ENREF_15
- _ENREF_16
- _ENREF_17
- _ENREF_18
- _ENREF_19
- _ENREF_20
- _ENREF_21
- _ENREF_22
- _ENREF_23
- _ENREF_24
- _ENREF_25
- _ENREF_26
- _ENREF_27General absorption models
- Delays in absorption
- Convolution & deconvolution
- Formulation effect in drug delivery
- Physiologically based absorption model
- Mechanism-based PK/PD modeling & drug delivery
- Conclusion
- _ENREF_1
- _ENREF_2
- _ENREF_4
- _ENREF_5
- _ENREF_6
- _ENREF_7
- _ENREF_8
- _ENREF_9
- _ENREF_10
- _ENREF_11
- _ENREF_12
- _ENREF_13
- _ENREF_14
- _ENREF_15
- _ENREF_16
- _ENREF_17
- _ENREF_18
- _ENREF_19
- _ENREF_20
- _ENREF_21
- _ENREF_22
- _ENREF_23
- _ENREF_3
- _ENREF_1_ENREF_2
- _ENREF_3
- _ENREF_4
- _ENREF_5
- _ENREF_6
- _ENREF_7
- _ENREF_8
- _ENREF_9
- _ENREF_10
- _ENREF_11
- _ENREF_12
- _ENREF_13
- _ENREF_14
- _ENREF_15
- _ENREF_16
- _ENREF_17
- _ENREF_18
- _ENREF_19
- _ENREF_20
- _ENREF_21
- _ENREF_22
- _ENREF_23
- _ENREF_24
- _ENREF_25
- _ENREF_27
- _ENREF_28
- _ENREF_1
- OLE_LINK3
- OLE_LINK4
- _ENREF_2
- _ENREF_3
- _ENREF_4
- _ENREF_5
- _ENREF_6
- _ENREF_7
- _ENREF_8
- _ENREF_9
- _ENREF_10
- _ENREF_11
- _ENREF_12